Search research articles
Contact Us
Filters
Showing results (51-60 of 121) with videos related to
Page
of 13
Sort By:
Rheumatology (Oxford, England)
|
July 31, 2023
The impact of 2023 EMA recommendations on patients treated with JAK inhibitors: real-life experience from a prospective monocentric cohort
Alessandro Tomelleri, Giovanni Benanti, Adriana Cariddi, et al.
Seminars in Arthritis and Rheumatism
|
February 12, 2023
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study
Alessandro Tomelleri, Corrado Campochiaro, Nicola Farina, et al.
RMD Open
|
November 8, 2020
Efficacy and safety of tocilizumab in giant cell arteritis: a single centre NHS experience using imaging (ultrasound and PET-CT) as a diagnostic and monitoring tool
Alwin Sebastian, Abdul Kayani, Diana Prieto-Pena, et al.
Arthritis Care & Research
|
July 17, 2024
Impact of Exposure to Environmental Particulate Matter on the Onset of Giant Cell Arteritis
Milena Bond, Alessandro Tomelleri, Maria A Reatini, et al.
Rheumatology (Oxford, England)
|
November 14, 2020
Living with fibromyalgia during the COVID-19 pandemic: mixed effects of prolonged lockdown on the well-being of patients
Giulio Cavalli, Adriana Cariddi, Jacopo Ferrari, et al.
Oncoimmunology
|
July 7, 2017
Tocilizumab in patients with multisystem Erdheim-Chester disease
Alvise Berti, Giulio Cavalli, Barbara Guglielmi, et al.
Journal of Clinical Ultrasound : JCU
|
December 22, 2022
Cardiac magnetic resonance findings in acute and post-acute COVID-19 patients with suspected myocarditis
Anna Palmisano, Davide Vignale, Elisa Bruno, et al.
Rheumatology (Oxford, England)
|
May 14, 2025
Secukinumab is effective and safe for patients with giant cell arteritis after tocilizumab failure
Alessandro Tomelleri, Milena Bond, Chiara Marvisi, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
December 3, 2019
Tocilizumab for the Treatment of Myocardial Inflammation Shown by Cardiac Magnetic Resonance: Report of Two Cases and Rationale for Its Therapeutic Use
Corrado Campochiaro, Giacomo De Luca, Alessandro Tomelleri, et al.
La Radiologia Medica
|
March 22, 2023
Cardiovascular involvement in Erdheim-Chester diseases is associated with myocardial fibrosis and atrial dysfunction
Anna Palmisano, Corrado Campochiaro, Davide Vignale, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 121) with videos related to
Sort By:
Page
of 13
Rheumatology (Oxford, England)
|
July 31, 2023
The impact of 2023 EMA recommendations on patients treated with JAK inhibitors: real-life experience from a prospective monocentric cohort
Alessandro Tomelleri, Giovanni Benanti, Adriana Cariddi, et al.
Seminars in Arthritis and Rheumatism
|
February 12, 2023
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study
Alessandro Tomelleri, Corrado Campochiaro, Nicola Farina, et al.
RMD Open
|
November 8, 2020
Efficacy and safety of tocilizumab in giant cell arteritis: a single centre NHS experience using imaging (ultrasound and PET-CT) as a diagnostic and monitoring tool
Alwin Sebastian, Abdul Kayani, Diana Prieto-Pena, et al.
Arthritis Care & Research
|
July 17, 2024
Impact of Exposure to Environmental Particulate Matter on the Onset of Giant Cell Arteritis
Milena Bond, Alessandro Tomelleri, Maria A Reatini, et al.
Rheumatology (Oxford, England)
|
November 14, 2020
Living with fibromyalgia during the COVID-19 pandemic: mixed effects of prolonged lockdown on the well-being of patients
Giulio Cavalli, Adriana Cariddi, Jacopo Ferrari, et al.
Oncoimmunology
|
July 7, 2017
Tocilizumab in patients with multisystem Erdheim-Chester disease
Alvise Berti, Giulio Cavalli, Barbara Guglielmi, et al.
Journal of Clinical Ultrasound : JCU
|
December 22, 2022
Cardiac magnetic resonance findings in acute and post-acute COVID-19 patients with suspected myocarditis
Anna Palmisano, Davide Vignale, Elisa Bruno, et al.
Rheumatology (Oxford, England)
|
May 14, 2025
Secukinumab is effective and safe for patients with giant cell arteritis after tocilizumab failure
Alessandro Tomelleri, Milena Bond, Chiara Marvisi, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases
|
December 3, 2019
Tocilizumab for the Treatment of Myocardial Inflammation Shown by Cardiac Magnetic Resonance: Report of Two Cases and Rationale for Its Therapeutic Use
Corrado Campochiaro, Giacomo De Luca, Alessandro Tomelleri, et al.
La Radiologia Medica
|
March 22, 2023
Cardiovascular involvement in Erdheim-Chester diseases is associated with myocardial fibrosis and atrial dysfunction
Anna Palmisano, Corrado Campochiaro, Davide Vignale, et al.
Page
of 13